Please Wait.....
Report
Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2023-2028
Market Report I 2023-11-02 I 144 Pages I IMARC Group
The global digital therapeutics market size reached US$ 5.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2028, exhibiting a growth rate (CAGR) of 20.1% during 2022-2028. The growing demand for digital behavior-monitoring treatment, increasing prevalence of chronic diseases, and rising awareness among the masses about personal health and fitness represent one of the key factors driving the market.
Increasing Usage of Smartphones and Tablets Propelling Market Growth
The rising reliance on smartphones and tablets, coupled with different healthcare apps, is propelling the growth of the digital therapeutics market. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. The increasing utilization of personal technological devices in healthcare is catalyzing the demand for digital therapeutics (DTx) treatments. DTx is enhancing patient access to the safety and effectiveness of treatments, presenting information in different languages, providing relevant information about diseases and treatments, and expanding the ability of physicians to care for patients. Furthermore, it is an advanced mode of care delivery, which can be easily implemented at home and eliminates any stigma associated with traditional therapies.
Digital Therapeutics Market Trends:
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of a large number of global and regional players. Moreover, the competitive environment in this market is intensifying due to the increasing number of research and development (R&D) innovations and mergers and acquisitions (M&A). The volume of new entrants is moderate in the digital therapeutics industry due to the fragmented market structure and low product differentiation and switching cost. In addition, the growing number of mhealth developers is contributing to the high threat of new entrants. However, the requirement of patents and high costs of advanced technologies along with stringent regulatory procedures, decreases the threat from new entrants.
What are Digital Therapeutics?
Digital therapeutics (DTx) is an evidence-based therapeutic intervention driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. It is a form of a software-as-a-medical device (SaMD) that relies on software interventions to bring about behavioral changes in patients and help treat their conditions. DTx is a fast-emerging class of therapies that utilizes software to treat disease as a standalone or for treatment optimization. It assists in preventing and managing a wide variety of diseases and conditions, such as type 2 diabetes, congestive heart failure, obesity, Alzheimer's disease, dementia, asthma, substance abuse, attention deficit hyperactivity disorder (ADHD), hypertension, anxiety, depression, and several others. DTx also aids in improving patient medication adherence and supporting healthcare professionals (HCPs) to manage their patients and businesses digitally.
COVID-19 Impact:
The arrival of the COVID-19 pandemic can be described as a watershed moment for the healthcare industry. It changed the manner of healthcare delivery dramatically while exposing the lack of preparedness on the part of governments worldwide to adequately tackle a global healthcare emergency. Frontline health workers were involved in managing COVID-19 patients, but patients with other health conditions, especially chronic health conditions, experienced difficulties as their in-clinic visits were postponed or avoided. Moreover, as the outcomes of COVID-19 among patients with comorbidities, especially obesity, heart complications, and diabetes, were worse than those without, these patients were asked to be additionally vigilant. The pandemic also brought a fair share of mental health disorders, including depression, anxiety, and withdrawals, and their management was a challenge due to the lack of face-to-face visits. These interconnected events have made healthcare providers look out for digital health solutions to tackle health crisis. There was a positive trend observed during the COVID-19 outbreak in relation to the adoption of digital health technologies, which increased the efficiency and effectiveness of healthcare operations and service delivery. After the pandemic started, the adoption of DTx applications in various fields accelerated many folds. Additionally, the COVID-19 pandemic increased the adoption of virtual and home care technologies by transforming patient engagement and integrating data across the healthcare landscape.
Digital Therapeutics Market Trends:
At present, there is a rise in the demand for DTx among type 2 diabetes patients to manage the disease and enable them to use the internet of things (IoT)-enabled insulin pumps and other health monitoring systems. This, along with the increasing demand for digital behavior-monitoring treatment to ensure medication adherence and healthy lifestyle changes, represents one of the key factors supporting the growth of the market. In addition, the growing utilization of DTx to reduce the need for more follow-up checkups and relapses compared to traditional treatments is offering a favorable market outlook. Moreover, there is an increase in the prevalence of chronic diseases, such as heart disease, stroke, cancer, obesity, and arthritis. This, coupled with the rising awareness among the masses about personal health and fitness, is propelling the growth of the market. Additionally, the escalating demand for DTx to help doctors manage patient adherence to medical regimens and build an integrated health ecosystem that can enable the seamless transfer of data between different stakeholders, such as payers, providers, and pharmacies, is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application and end use.
Application Insights:
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others
The report has provided a detailed breakup and analysis of the digital therapeutics market based on the application. This includes diabetes, obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others. According to the report, diabetes represented the largest segment due to the rising prevalence of diabetes, along with the high risk of associated conditions, such as cardiac arrests, kidney failure, and blindness, in diabetic patients. Moreover, the growing integration of DTx with numerous medical devices, such as insulin pumps, glucose blood meters, and wearable gadgets, is positively influencing the market.
End Use Insights:
Patients
Providers
Payers
Employers
Others
A detailed breakup and analysis of the digital therapeutics market based on the end use has also been provided in the report. This includes patients, providers, payers, employers, and others. According to the report, patients accounted for the largest market share due to the rising adoption of DTx among patients for numerous associated benefits pertaining to elective health management at an affordable cost. In addition, the increasing consumer inclination towards patient management systems for improving retention and compliance with post hospitalization follow-up visits is catalyzing the demand for DTx.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for digital therapeutics. Some of the factors driving the North America digital therapeutics market included the growing geriatric population, continuous upgradations in drug approval processes by the Food and Drug Administration (FDA), rising awareness about the benefits of DTx, etc. In addition, the growing utilization of DTx as a standalone therapy or in conjunction with medications, devices, and other therapies to optimize patient care and healthcare outcomes is offering a favorable market outlook.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global digital therapeutics market. Some of the companies covered in the report include:
2Morrow Inc.
Canary Health Inc.
Click Therapeutics Inc.
Mango Health Inc. (TrialCard Incorporated)
Noom Health Inc.
Omada Health Inc.
Pear Therapeutics, Inc.
Propeller Health (ResMed)
Teladoc Health Inc.
Voluntis Inc.
WellDoc Inc.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global digital therapeutics market in 2022?
2. What is the expected growth rate of the global digital therapeutics market during 2023-2028?
3. What are the key factors driving the global digital therapeutics market?
4. What has been the impact of COVID-19 on the global digital therapeutics market?
5. What is the breakup of the global digital therapeutics market based on the application?
6. What is the breakup of the global digital therapeutics market based on the end use?
7. What are the key regions in the global digital therapeutics market?
8. Who are the key players/companies in the global digital therapeutics market?
1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 Executive Summary
4 Introduction
4.1Overview
4.2Key Industry Trends
5 Global Digital Therapeutics Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 Market Breakup by Application
6.1Diabetes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Obesity
6.2.1 Market Trends
6.2.2 Market Forecast
6.3CVD
6.3.1 Market Trends
6.3.2 Market Forecast
6.4CNS Disease
6.4.1 Market Trends
6.4.2 Market Forecast
6.5Respiratory Diseases
6.5.1 Market Trends
6.5.2 Market Forecast
6.6Smoking Cessation
6.6.1 Market Trends
6.6.2 Market Forecast
6.7Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by End Use
7.1Patients
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Providers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3Payers
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Employers
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1Overview
9.2Strengths
9.3Weaknesses
9.4Opportunities
9.5Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1Overview
11.2Bargaining Power of Buyers
11.3Bargaining Power of Suppliers
11.4Degree of Competition
11.5Threat of New Entrants
11.6Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1Market Structure
13.2Key Players
13.3Profiles of Key Players
13.3.12Morrow Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2Canary Health Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3Click Therapeutics Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4Mango Health Inc. (TrialCard Incorporated)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5Noom Health Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6Omada Health Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7Pear Therapeutics, Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8Propeller Health (ResMed)
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9Teladoc Health Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.10Voluntis Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11WellDoc Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2022
Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2022
Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2022
Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis
Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Digital Therapeutics Market: Competitive Structure
Table 6: Global: Digital Therapeutics Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security